AD Diagnostics

Neurons plaque


Enabling people and their physicians to make the right decisions….and change their lives

Clinical researchers believe that early detection will be key to preventing, slowing and stopping Alzheimer’s disease. In 2011, the National Institute on Aging and the Alzheimer’s Association proposed revised criteria and guidelines for diagnosing Alzheimer’s disease. The guidelines recommend that Alzheimer’s be considered a slowly progressive brain disease that begins presymptomatically well before clinical symptoms emerge. In today’s healthcare environment, diagnostic technologies are an integral part of decision-making along the entire continuum of a patient’s health or disease:


Diagnostics can impact healthcare today:

  • Empowering physicians to make the right decisions for their patients at the right time
  • Allowing people to have improved control over their health and wellbeing
  • Giving payers and policymakers the confidence that they are investing in the right solutions for patients and the future of healthcare.
  • Modern diagnostics reduces costs by diminishing subsequent health problems, reducing hospitalization and avoiding unnecessary treatment.

The future of sustainable healthcare depends on diagnostics.